Medical Condition News

RSS

FDA clears QbTest for unbiased evaluation of ADHD treatment

The US Food and Drug Administration (FDA) has cleared the neuropsychological test - QbTest - developed by the Swedish company Qbtech to aid in the evaluation of treatment interventions in patients with ADHD.

2 Apr 2014

Synthon’s SYD985 ADC demonstrates anti-tumor activity, outperforms leading anti-HER2 ADC

Synthon Biopharmaceuticals today announced the results of a head-to-head comparative program of its antibody-drug conjugate (ADC) SYD985 with Roche's market leading anti-HER2 ADC, T-DM1 (Kadcyla).

2 Apr 2014

$International Osteoporosis Foundation launches FRAX App to assess risk of osteoporotic fracture$

International Osteoporosis Foundation launches FRAX App to assess risk of osteoporotic fracture

Osteoporosis management guidelines around the world now recommend that fracture risk assessment be part of any clinical evaluation for osteoporosis. As a result, rather than relying on bone mineral density values alone, physicians now consider future fracture risk when making treatment decisions.

2 Apr 2014

New therapeutic agent reduces age-related sleep problems in fruit flies

Elderly flies do not sleep well - they frequently wake up during the night and wander around restlessly. The same is true of humans. For researchers at the Max Planck Institute for Biology of Ageing in Cologne, the sleeplessness experienced by the fruit fly Drosophila is therefore a model case for human sleeping behaviour.

2 Apr 2014

Uric acid in urine generates potentially hazardous in swimming pools by interacting with chlorine

A new study shows how uric acid in urine generates potentially hazardous "volatile disinfection byproducts" in swimming pools by interacting with chlorine, and researchers are advising swimmers to observe "improved hygiene habits.

2 Apr 2014

Leading researchers to convene at 4th Annual Traumatic Brain Injury Conference

The world's leading researchers in the field of traumatic brain injury research are meeting on April 16 & 17, 2014 in Washington DC for the 4th Annual Traumatic Brain Injury Conference.

2 Apr 2014

Study finds that stress can make allergies worse

Stress doesn't cause allergies, but easing your mind might mean less allergy flare-ups this spring. According to a study published in the April issue of Annals of Allergy, Asthma & Immunology, the scientific journal of the American College of Allergy, Asthma and Immunology, allergy sufferers with persistent stress experience more allergy flares.

2 Apr 2014

ANP reports positive results from chronic toxicity study of ATL1102 in multiple sclerosis

Antisense Therapeutics Limited is pleased to advise that results from a chronic toxicity study in monkeys indicate that ATL1102, an antisense oligonucleotide currently under development for the treatment of multiple sclerosis (MS), was well-tolerated when given subcutaneously for a 6-month dosing period at the 2 dose levels tested (1.5 and 3mg/kg/dose).

2 Apr 2014

Researchers discover involvement of common gut bacterium in bowel cancer

New evidence that a common gut bacterium is involved in bowel cancer has been discovered by researchers from the Department of Physiology and Medical Physics in RCSI (Royal College of Surgeons in Ireland). The research is published in this month’s edition of the European Journal of Clinical Microbiology & Infectious Diseases.

2 Apr 2014

Researchers find potential way to ease physical damage of numerous genetic disorders

Duke Medicine researchers studying tiny, antennae-like structures called cilia have found a potential way to ease some of the physical damage of numerous genetic disorders that result when these essential cellular components are defective.

2 Apr 2014

FDA approves ORALAIR sublingual allergy immunotherapy tablet

GREER Laboratories, Inc., a leading developer and provider of allergy immunotherapy products and services, today announced that the U.S. Food and Drug Administration has approved ORALAIR (Sweet Vernal, Orchard, Perennial Rye, Timothy and Kentucky Blue Grass Mixed Pollens Allergen Extract) sublingual allergy immunotherapy tablet.

2 Apr 2014

10% of neurosurgeons follow routine psychological screenings of patients prior to back surgery

In a report published in the April edition of the Journal of Spinal Disorders and Techniques, a Johns Hopkins team says that only 10 percent of orthopaedic surgeons and neurosurgeons follow professional guidelines recommending routine psychological screenings of patients prior to major surgery for severe back and leg pain.

2 Apr 2014

FDA grants orphan drug designation to ERYTECH’s lead product for AML treatment

ERYTECH Pharma, a French biopharmaceutical company that develops innovative treatments for acute leukemia and other oncology indications with unmet medical needs, announces that its lead product GRASPA®/ERY-ASP has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for the treatment of Acute Myeloid Leukemia (AML), an aggressive form of blood cancer.

2 Apr 2014

New imaging tool provides fresh insight into origins of Alzheimer's, Parkinson's disease

Researchers at Lancaster University have invented a new imaging tool inspired by the humble sewing machine which is providing fresh insight into the origins of Alzheimer's and Parkinson's disease.

2 Apr 2014

iPhone app uses science to help people with acne make better food choices

Acne sufferers around the world are using an iPhone app created at Northwestern University to learn how certain foods affect their skin conditions.

2 Apr 2014

Evotec signs research collaboration and licensing deal with Debiopharm Group

Evotec AG announced today a research collaboration and licensing deal with Debiopharm Group™, Lausanne, Switzerland.

2 Apr 2014

UCLA scientist wins $3M gift for research on structural properties of key proteins in kidney

UCLA Scientist Dr. Ira Kurtz has received a $3 million gift from the Donald T. Sterling Foundation to fund research on the structural properties of key proteins in the kidney that affect its function in health and disease.

2 Apr 2014

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Reinforcing its position as a global leader in bringing new therapies to patients with heart and cardiovascular disease, Boston Scientific Corporation (NYSE: BSX) reported favorable results in studies related to cardiac resynchronization therapy (CRT), platinum chromium stent platforms and transcatheter aortic valve replacement (TAVR).

2 Apr 2014

Study: Obesity causes changes in colon that may lead to colorectal cancer

Obesity, rather than diet, causes changes in the colon that may lead to colorectal cancer, according to a study in mice by the National Institutes of Health. The finding bolsters the recommendation that calorie control and frequent exercise are not only key to a healthy lifestyle, but a strategy to lower the risk for colon cancer, the second leading cause of cancer-related death in the United States.

2 Apr 2014

RPCI receives FDA approval to enroll patients in phase II clinical trial using I-PDT approach

Roswell Park Cancer Institute (RPCI) has received U.S. Food and Drug Administration (FDA) approval to enroll patients in a phase II clinical trial that will use a unique and highly precise method of delivering interstitial photodynamic therapy (I-PDT) to recurrent tumors of the head and neck.

2 Apr 2014

Medical Condition News

FDA clears QbTest for unbiased evaluation of ADHD treatment

Synthon’s SYD985 ADC demonstrates anti-tumor activity, outperforms leading anti-HER2 ADC

International Osteoporosis Foundation launches FRAX App to assess risk of osteoporotic fracture

New therapeutic agent reduces age-related sleep problems in fruit flies

Uric acid in urine generates potentially hazardous in swimming pools by interacting with chlorine

Leading researchers to convene at 4th Annual Traumatic Brain Injury Conference

Study finds that stress can make allergies worse

ANP reports positive results from chronic toxicity study of ATL1102 in multiple sclerosis

Researchers discover involvement of common gut bacterium in bowel cancer

Researchers find potential way to ease physical damage of numerous genetic disorders

FDA approves ORALAIR sublingual allergy immunotherapy tablet

10% of neurosurgeons follow routine psychological screenings of patients prior to back surgery

FDA grants orphan drug designation to ERYTECH’s lead product for AML treatment

New imaging tool provides fresh insight into origins of Alzheimer's, Parkinson's disease

iPhone app uses science to help people with acne make better food choices

Evotec signs research collaboration and licensing deal with Debiopharm Group

UCLA scientist wins $3M gift for research on structural properties of key proteins in kidney

Boston Scientific presents new data on cardiology-related clinical trials at ACC 2014

Study: Obesity causes changes in colon that may lead to colorectal cancer

RPCI receives FDA approval to enroll patients in phase II clinical trial using I-PDT approach

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News